Read + Share
. Effect of combination treatment with glucagon-like peptide-1 receptor agonists
and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and
serious renal events: population based cohort study. BMJ 2024;385:q1094.
PMID: 38754911
|
 |
|
